Lantern Pharma Inc. logo

Lantern Pharma Inc.

NASDAQ:LTRN

Overview | Financials
Company Name Lantern Pharma Inc.
Symbol LTRN
Currency USD
Price 3.42
Market Cap 36,815,274
Dividend Yield 0%
52-week-range 2.38 - 11.99
Industry Biotechnology
Sector Healthcare
CEO Mr. Panna Sharma PH.D.
Website https://www.lanternpharma.com

An error occurred while fetching data.

About Lantern Pharma Inc.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a

Related Stocks

BioVie Inc. logo

BioVie Inc.

BIVI

2.49 USD

Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc.

ACHV

4.165 USD

CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

CASI

6.5 USD

Dyadic International, Inc. logo

Dyadic International, Inc.

DYAI

1.26 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.19 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

1.79 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.87 USD

Financials

Numbers are in millions USD

Numbers are in millions USD